TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental ...
In recent years, there has been much debate about the role of traditional therapy in psychedelic-assisted therapy. Some argue that the medicines are the primary agents of change, needing only minimal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback